Literature DB >> 7882315

DNA strand break rejoining defect in xrs-6 is complemented by transfection with the human Ku80 gene.

G M Ross1, J J Eady, N P Mithal, C Bush, G G Steel, P A Jeggo, T J McMillan.   

Abstract

The radiosensitive mutant xrs-6, derived from Chinese hamster ovary cell line CHO-K1, has been demonstrated to be defective in DNA double-strand break repair and also in its proficiency to undergo V(D)J recombination. Recent work has provided both genetic and biochemical evidence that the M(r) 80,000 subunit of the Ku protein is able to complement the radiosensitivity and the V(D)J recombination defect in the xrs-6 mutant. We demonstrate here that complementation of the radiosensitive phenotype in xrs-6 cells by the introduction of Ku80 cDNA is accompanied by the concomitant restoration of DNA double-strand break rejoining proficiency to almost that of the parental CHO-K1 cells, as measured both by neutral single-cell microgel electrophoresis (Comet) technique and by pulsed-field gel electrophoresis. These results provide further biochemical evidence for the involvement of the Ku protein in the repair of DNA double-strand breaks.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882315

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  A Ku80 fragment with dominant negative activity imparts a radiosensitive phenotype to CHO-K1 cells.

Authors:  E Marangoni; N Foray; M O'Driscoll; S Douc-Rasy; J Bernier; J Bourhis; P Jeggo
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

2.  UV sensitivity and impaired nucleotide excision repair in DNA-dependent protein kinase mutant cells.

Authors:  C Muller; P Calsou; P Frit; C Cayrol; T Carter; B Salles
Journal:  Nucleic Acids Res       Date:  1998-03-15       Impact factor: 16.971

3.  DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM) promote cell survival in response to NK314, a topoisomerase IIα inhibitor.

Authors:  Lei Guo; Xiaojun Liu; Yingjun Jiang; Kiyohiro Nishikawa; William Plunkett
Journal:  Mol Pharmacol       Date:  2011-05-05       Impact factor: 4.436

4.  Response to multiple radiation doses of human colorectal carcinoma cells infected with recombinant adenovirus containing dominant-negative Ku70 fragment.

Authors:  Muneyasu Urano; Fuqiu He; Akiko Minami; C Clifton Ling; Gloria C Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-01       Impact factor: 7.038

5.  LSD1 regulates the FOXF2-mediated Wnt/β-catenin signaling pathway by interacting with Ku80 to promote colon cancer progression.

Authors:  Zhenhua Liu; Jingjing Xiao; Ning Wang; Jie Ding
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

6.  Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends.

Authors:  Josée Guirouilh-Barbat; Emilie Rass; Isabelle Plo; Pascale Bertrand; Bernard S Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

7.  Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions.

Authors:  Ryan Jensen; Peter M Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-06       Impact factor: 11.205

8.  PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.

Authors:  Minli Wang; Weizhong Wu; Wenqi Wu; Bustanur Rosidi; Lihua Zhang; Huichen Wang; George Iliakis
Journal:  Nucleic Acids Res       Date:  2006-11-06       Impact factor: 16.971

9.  Expression of Ku70 correlates with survival in carcinoma of the cervix.

Authors:  C R Wilson; S E Davidson; G P Margison; S P Jackson; J H Hendry; C M West
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.

Authors:  Zun-yi Zhang; Sheng-ling Fu; Su-qin Xu; Xiao Zhou; Xian-shen Liu; Yong-jian Xu; Jian-ping Zhao; Shuang Wei
Journal:  Oncotarget       Date:  2015-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.